MindMed Archives | High Times

New York
News
Psychedelics

Biotech Firm Launches Trial To Study LSD As Treatment For Anxiety

New York-based biopharmaceutical developer MindMed announced last week that it has dosed the first patient in a clinical trial of LSD as a treatment for generalized anxiety disorder.

byA.J. Herrington

August 29, 2022

The Latest

Getting All of Comedian Joel Kim Booster

Study: Low-Dose CBD as Effective as Melatonin for Improving Sleep

Frequent Pot Users Slimmer than Non-Users, Mouse Study Suggests

Rhode Island Ushers In New Era for Medical Weed Patients with Digital Applications

MindMed

Biotech Firm Launches Trial To Study LSD As Treatment For Anxiety

Getting All of Comedian Joel Kim Booster

Study: Low-Dose CBD as Effective as Melatonin for Improving Sleep

Frequent Pot Users Slimmer than Non-Users, Mouse Study Suggests

Rhode Island Ushers In New Era for Medical Weed Patients with Digital Applications

Calm in Your Cup